Home - Products - Others - Other Targets - Tectorigenin-7-O-beta-glucosyl-4-O-beta-glucoside

Tectorigenin-7-O-beta-glucosyl-4-O-beta-glucoside

CAS No. 848128-32-5

Tectorigenin-7-O-beta-glucosyl-4-O-beta-glucoside( —— )

Catalog No. M32556 CAS No. 848128-32-5

The roots of Pueraria lobata.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 551 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Tectorigenin-7-O-beta-glucosyl-4-O-beta-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    The roots of Pueraria lobata.
  • Description
    The roots of Pueraria lobata.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    848128-32-5
  • Formula Weight
    624.6
  • Molecular Formula
    C28H32O16
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO, Pyridine, Methanol, Ethanol, etc.
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Chamaejasmenin B

    Chamaejasmenin B is a compound isolated from Stellera chamaejasme L. Chamaejasmenin B has anticancer and antitumor activity, inhibiting cancer cell migration and invasion, and inhibiting tumor metastasis.Chamaejasmenin B is used in the study of cancers such as breast cancer.

  • CNT2 inhibitor-1

    CNT2 inhibitor-1 is a potent inhibitor of concentrative nucleoside transporter 2 (CNT2; IC50: 640 nM for hCNT2).

  • [Lys3]–Bombesin

    [Lys3]-Bombesin is a biological active peptide. (PET (Positron Emission Tomography) imaging of [Lys3]-bombesin is able to detect gastrin-releasing peptide receptor (GRPR) positive prostate cancer. An immunoconjugate of [Lys3]-bombesin and corresponding monoclonal antibody can specifically induce (CD64)-dependent monocyte and neutrophil-mediated lysis of small cell carcinoma.)